MarginsXMarginsX
Home › Markets › Health Care › NTHI

NeOnc Technologies Holdings Inc. (NTHI)

NTHI trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$4.54
-7.54% on the day
Market cap
$131.0M
Micro cap
Revenue · 2025
$40K
-51.8% on 2024
Net income · 2025
-$62.1M
-155404.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1979414/000182912626002860/0001829126-26-002860-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerNTHI on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001979414
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$40K
Net income-$62.1M
Operating income-$58.2M
Net margin-155404.4%
Operating margin-145637.5%
Revenue growth-51.8%
Cash$59K
Total assets$2.8M
P/E (computed)Net income was not positive
P/S (computed)3275.4×

Warning signs

Cash runway
3.6 months
$6.2M cash at September 30, 2026
Share count, 1 year
+48.1%
2025-11-14 to 2026-11-05
Going-concern doubt
Yes
10-Q filed November 5, 2026
Insider net buying, 12 months
$1.3M
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors raise substantial doubt regarding the Company's ability to continue as a going concern one year from the issuance date of this Form 10-Q."
10-Q 2026-11-05
Cash and burn$6.2M cash; operating cash flow -$5.1M a quarter.Report 2026-09-30
Shares outstanding28,850,588 (2026-11-05); 19,474,303 a year earlier.Cover page 2026-11-05
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months3 S-3/F-3 shelf filings; 6 424B5 takedowns, 2 at the marketLatest 2026-09-10
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorCBIZ CPAs P.C., Philadelphia, Pennsylvania, United States; changed auditors 1 time in 24 months8-K 4.01 2025-04-01
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $1.3M, sold $17K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$0-$4.4M-$5.1M$6.2MNo debt tagsNeeds four quarters10-Q 2026-11-05
Q2 2026
2026-06-30
$0-$14.2M-$4.8M$2.0MNo debt tagsNeeds four quarters10-Q 2026-08-10
Q1 2026
2026-03-31
Not filed-$8.8M-$7.0M$139KNo debt tagsNeeds four quarters10-Q 2026-05-15
Q4 2025
2025-12-31
$0-$15.5M-$3.6M$59K$6.0M$40K10-K 2026-03-31
Q3 2025
2025-09-30
$0-$8.6M-$5.8M$1.5M$4.7M$60K10-Q 2025-11-14
Q2 2025
2025-06-30
$0-$5.7M-$5.3M$125KNo debt tags$60K10-Q 2025-08-18
Q1 2025
2025-03-31
$40K-$32.3M-$5.7M$5.4M$11.4M$80K10-Q 2026-05-15
Q4 2024
2024-12-31
$20K-$2.3M-$954K$65K$11.7M$83K10-K 2026-03-31

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-09-10
Latest annual report10-K/A2026-05-05
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-13
Latest proxyDEFA14A2026-06-23

Source: SEC EDGAR submissions feed, 215 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+40.7%
1 month+89.2%
3 months+53.0%
Year to date-40.6%
1 year-45.3%
From 52-week high-54.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
CNTNCanton Strategic Holdings Inc.$1.64-4.09%$130.7M
MENSJyong Biotech Ltd.$1.77+0.57%$134.6M
MSLESatellos Bioscience Inc.$6.47-2.34%$137.3M
ALXOALX Oncology Holdings Inc.$1.00-3.85%$124.9M
AKBAAkebia Therapeutics Inc.$0.4486-5.40%$124.6M
MGNXMacroGenics Inc.$2.17-1.36%$138.7M
RNAAtrium Therapeutics Inc.$6.43-14.38%$138.7M
SIONSionna Therapeutics Inc.$3.12-6.31%$141.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier